Xencor Inc (XNCR)
Latest XNCR Insider Trades
- Ellen Feigal - DirectorOpen-market sale$89K
Kevin Charles Gorman - Director
About Xencor Inc (XNCR)
Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.
- PASADENA, CA
- 260
- 2013
- XNAS
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 5 | 30,382 | $379K |
| Grant or award | 16 | 247,248 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
XNCR Insider Transactions (Form 4)
6937 Form 4 filings on record, the earliest from Oct 1, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Ellen Feigal - Director | Grant or award | Common Stock | 10,302 |
Recent XNCR Form 8-K Filings
5Recent XNCR Form 144 Notices of Proposed Sale
3A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - |
XNCR Insider Trading - FAQ
What is the latest insider trade for XNCR?
Xencor Inc (XNCR) had 13 insider filings in the last 90 days, with the most recent on 2026-07-08. The full record for XNCR runs to 37 Form 4 filings, the earliest from 2024-10-01. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying XNCR stock?
No insider purchases of XNCR were filed in the last 90 days.
How many insiders are selling XNCR stock?
5 insider sales of XNCR were filed in the last 90 days, totaling $379K.
Where can I see XNCR SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks XNCR Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow XNCR insider buys?
Create a free InsiderAlpha account and press Watch on this page to add XNCR to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Ellen Feigal view on EDGAR
- - Kevin Charles Gorman view on EDGAR
- - Kurt A. Gustafson view on EDGAR
- - Barbara Klencke view on EDGAR
- - Alan Bruce Montgomery view on EDGAR
- - Richard J. Ranieri view on EDGAR
- - Todd E. Simpson view on EDGAR
- - Raymond Joseph Deshaies view on EDGAR
- - Ellen Feigal view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where XNCR's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track XNCR insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
